Cargando…

Hypofractionated Whole-Breast Irradiation Focus on Coronary Arteries and Cardiac Toxicity—A Narrative Review

Breast cancer is the most common cancer among women worldwide, which is often treated with radiotherapy. Whole breast irradiation (WBI) is one of the most common types of irradiation. Hypo-fractionated WBI (HF-WBI) reduces the treatment time from 5 to 3 weeks. Recent radiobiological and clinical evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mireştean, Camil Ciprian, Iancu, Roxana Irina, Iancu, Dragoş Petru Teodor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021451/ https://www.ncbi.nlm.nih.gov/pubmed/35463375 http://dx.doi.org/10.3389/fonc.2022.862819

Ejemplares similares

New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg’ effect discovery
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

An Underestimated Toxicity Radiation-Induced Hypothyroidism in Patients Multimodally Treated for Breast Cancer
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Active Immune Phenotype in Head and Neck Cancer: Reevaluating the Iso-Effect Fractionation Based on the Linear Quadratic (LQ) Model—A Narrative Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Education in Radiation Oncology—Current Challenges and Difficulties
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Image Guided Radiotherapy (IGRT) and Delta (Δ) Radiomics—An Urgent Alliance for the Front Line of the War against Head and Neck Cancers
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon—A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes—“Immunological Dose Painting”
por: Mireştean, Camil Ciprian, et al.
Publicado: (2020)

The Prognostic Value of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio, and Monocyte–Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)—A Retrospective Single Center Study and a Literature Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Head and Neck Low Grade Chondrosarcoma—A Rare Entity
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Radiotherapy challenges in COVID era
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Hypofractionated whole breast irradiation with simultaneous integrated boost in breast cancer using helical tomotherapy with or without regional nodal irradiation: A report of acute toxicities
por: Chitapanarux, Imjai, et al.
Publicado: (2023)

MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
por: Volovat, Simona Ruxandra, et al.
Publicado: (2020)

Cancer and Diabetes: Predictive Factors in Patients with Metabolic Syndrome
por: Stan, Mihai Cosmin, et al.
Publicado: (2023)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

Hypofractionated Irradiation Suppressed the Off-Target Mouse Hepatocarcinoma Growth by Inhibiting Myeloid-Derived Suppressor Cell-Mediated Immune Suppression
por: Chen, Junying, et al.
Publicado: (2020)

A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis
por: Gil, Gabriel Oliveira Bernardes, et al.
Publicado: (2023)

Lung-heart toxicity in a randomized clinical trial of hypofractionated image guided radiation therapy for breast cancer
por: Van Parijs, Hilde, et al.
Publicado: (2023)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Hypofractionation Radiotherapy vs. Conventional Fractionation for Breast Cancer: A Comparative Review of Toxicity
por: Youssef, Ashraf, et al.
Publicado: (2018)

Magnetic field dose effects on different radiation beam geometries for hypofractionated partial breast irradiation
por: Kim, Anthony, et al.
Publicado: (2017)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial
por: Xie, Jinrong, et al.
Publicado: (2022)

Hypofractionation: The standard for external beam breast irradiation
por: Brunt, Adrian Murray, et al.
Publicado: (2023)

Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer
por: Banfill, Kathryn, et al.
Publicado: (2022)

Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells
por: Gehre, Simon, et al.
Publicado: (2023)

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience
por: Musunuru, Hima Bindu, et al.
Publicado: (2014)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
por: Laursen, Michael, et al.
Publicado: (2018)

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: Swanson, William, et al.
Publicado: (2021)

Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor Thrombosis
por: Fang, Fang, et al.
Publicado: (2022)

Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors
por: Ciammella, Patrizia, et al.
Publicado: (2014)

Pulmonary Toxicity After Total Body Irradiation – Critical Review of the Literature and Recommendations for Toxicity Reporting
por: Vogel, Jennifer, et al.
Publicado: (2021)

Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery
por: Kim, Kyung Su, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h1lbie9cgeedmlukptd5k0vjfh